DEA-Licensed Cannabis Company Raises $20 Million
DEA-Licensed Pharmaceutical Cannabis Company Biopharmaceutical Research Company (BRC) Announces $20M Series A Funding Round. The Company... #BiopharmaceuticalResearchCompany #IntrinsicCapitalPartners
Stay updated with breaking news from Steven Hoffman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DEA-Licensed Pharmaceutical Cannabis Company Biopharmaceutical Research Company (BRC) Announces $20M Series A Funding Round. The Company... #BiopharmaceuticalResearchCompany #IntrinsicCapitalPartners
/PRNewswire/ -- Biopharmaceutical Research Company ("BRC"), an active Drug Enforcement Administration (DEA) pharmaceutical cannabis license holder, announced...
/PRNewswire/ -- Golden Grail Technology Corp (OTC: GOGY) https://goldengrailbeverages.com/ The Company is pleased to announce that the company has filed to...
Five years since its creation and now made up entirely of a second wave of commissioners, the Cannabis Control Commission and the legal marijuana sector that it oversees are at a critical crossroads and regulators are gearing up for a rulemaking round that one commissioner said could "make or break" the industry here.
Five years since its creation and now made up entirely of a second wave of commissioners, the Cannabis Control Commission and the legal marijuana sector that it oversees are at a critical crossroads and regulators are gearing up for a rulemaking round that one commissioner said could "make or break" the industry here.